C-MER Medical Holdings (stock code 03309) disclosed that on 28 November 2025, 220,000 ordinary shares were repurchased on the market at a repurchase price ranging from HKD 1.73 to HKD 1.74 per share, with an aggregate consideration of HKD 381,300. Following this transaction, the balance of ordinary shares (excluding treasury shares) changed from 1,237,992,870 to 1,237,772,870. The number of treasury shares increased to 17,788,000, and total issued shares remained at 1,255,560,870.

The repurchase took place under a mandate approved on 19 May 2025. The transaction accounted for approximately 0.0178% of the previously existing issued share capital (excluding treasury shares). Disclosures also highlighted various earlier repurchases (from mid-2024 to mid-2025), which remain in the process of cancellation. All such transactions were conducted in accordance with relevant listing rules, and the moratorium period for further share issuance or disposal of treasury shares lasts until 28 December 2025.